Comparative diagnostic accuracy of ACE-III and MoCA for detecting mild cognitive impairment patients with Parkinson’s disease
Objective: Due to the high prevalence of mild cognitive impairment (MCI) in Parkinson disease (PD), routine cognitive screening is important for the optimal management of…The interaction of Parkin and TAF15 for the Drosophila in which neuronal defect was induced
Objective: Our study proposes a novel regulator for the protection of TAF15-induced proteinopathy and adds to our understanding of the exact pathogenic mechanism for TAF15-induced…Effect of Combined Modality Treatment on Sustained Phonation in Parkinson’s Disease
Objective: To determine whether Lee Silverman Voice Treatment (LSVT-LOUD(R)) combined with Transcranial Magnetic Stimulation in individuals with Parkinson's disease (PD) improves phonation to a greater…An Analysis of Parkinson’s Disease Medication Treatment Patterns among Medicaid Patients
Objective: To describe patient demographic and medication utilization patterns within a state Medicaid program for patients diagnosed with Parkinson’s disease (PD). Background: Little is known…Parkinson’s Disease in Israel – Initial Symptoms and Comorbidities from 20 years of Follow Up in a Population-based Cohort
Objective: To describe the epidemiology of Parkinson’s disease (PD) in Israel during a 20-year period, 2000–2019, and to characterize initial symptoms and comorbidities of PD…Effects of Different Side-of-onset on Symptoms, Progression, and Prognosis in Parkinson’s Disease
Objective: We conducted an ambispective cohort study, with the largest number of involved patients for now, to assess whether the different side-of-onset could affect the…Short- and Long-term Healthcare Resource Utilization in Parkinson’s Disease – 20 years of Follow Up in a Population-based Cohort
Objective: To assess Parkinson’s disease (PD) burden by means of healthcare resource utilization (HCRU) and clinical outcomes in Israeli PD patients during 20-year period ,2000…Not so simple: the challenge of developing a non-motor symptoms app (NMS Assist) for people with Parkinson’s (PwP)
Objective: To evaluate usability and identify the challenges for PwP when using NMS Assist. Background: There is great potential for mHealth technologies, such as apps,…Enhancing the Proteasomal Degradation of Alpha Synuclein: “The Hallmark” to attenuating the Progression of Parkinson’s Disease
Objective: The research aimed at preventing the accumulation of Alpha Synuclein in order to prevent it's accumulation. It is imperative that we also establish that…Peripheral Blood Mononuclear Cells (PBMCs) are Useful Biomarkers of Mitochondrial Dysfunction in Parkinson Disease Patients with Pathogenic Parkin and LRRK2 Mutations
Objective: To investigate the use of PBMCs as a biomarker of mitochondrial dysfunction in Parkinson disease (PD) patients carrying pathogenic parkin or LRRK2 mutations. Background:…
- « Previous Page
- 1
- 2
- 3
- 4
- …
- 9
- Next Page »